WaferGen Launches the ICELL8(TM) Single-Cell System at ASHG

Company Presents Data Further Demonstrating Significant Benefits of ICELL8 Single-Cell System to Single-Cell Researchers

FREMONT, Calif., Oct. 6, 2015 -- WaferGen Bio-systems (WGBS) announced today the commercial launch and presentation of data from the ICELL8(TM) Single-Cell System at the American Society of Human Genetics (ASHG) annual meeting in Baltimore, MD.

In the hands of world-class early access partners globally, WaferGen's ICELL8 Single-Cell system has consistently demonstrated the power to isolate thousands of single-cells, the control to identify and process individual cells using CellSelect(TM) automated imaging and software and the ability to provide critical insight derived from running multiple samples or experiments on a single chip.

Read more: WaferGen Bio-systems ( WGBS )

WaferGen to Present New Single-Cell System Results at the Single Cell Genomics Meeting

Data Generated From Early Access Program Also to be Presented

FREMONT, Calif., Sept. 9, 2015-- WaferGen Bio-systems, Inc. (WGBS) will present results from the Company's single-cell analysis system at the Single Cell Genomics (SCG) Conference on September 16th, 2015, in Utrecht, The Netherlands. The presentation will highlight throughput and performance levels not previously achieved prior to the development of WaferGen's single-cell research platform (poster abstract code P036). In addition, data generated by the Company's single-cell early access partners utilizing WaferGen's technology will also be presented at the conference.

Read more: WaferGen Bio-systems Inc ( WGBS )

Dynasil's Hilger Crystals Subsidiary Enters into Supply Arrangement

NEWTON, Mass., Aug. 20, 2015  -- Dynasil Corporation of America (DYSL) today announced that Dynasil's UK subsidiary, Hilger Crystals, Ltd., entered into a three year arrangement to supply high-quality crystal components to a leading global supplier of security inspection equipment utilizing X-ray and gamma-ray imaging. 

"We are very happy to announce this agreement showcasing Hilger's expertise in crystal arrays and fabrication," said Peter Sulick, Dynasil's Chairman of the Board, Chief Executive Officer and President. 

"We believe that this new relationship may represent a significant growth opportunity for Hilger," said Jim Telfer, Managing Director of Hilger Crystals. "Being selected by this world-class company is a testament to the strength of our expertise in crystal technology and our development team," continued Mr. Telfer.  "Along with improvements in our physical plant, including new materials processing equipment, we will be increasing our staffing requirements as we scale up for this product."

Read more: Dynasil Corporation of America ( DYSL )

Sutron Corporation Agrees to Be Acquired by Hach Company Affiliate for $8.50 per Share

STERLING, VA and LOVELAND, CO--(June 22, 2015) - Sutron Corporation (STRN) and Hach Company are pleased to announce the entry into a definitive merger agreement, pursuant to which an affiliate of Hach Company will acquire Sutron Corporation by making a cash tender offer to acquire all outstanding shares of common stock of Sutron, at a purchase price of $8.50 per share, for a total enterprise value of approximately $39 million, net of cash.

Sutron would become a part of Hach Environmental, a group of companies including Ott Hydromet and Sea-Bird Scientific, that serves customers with high quality and reliable instruments focused on environmental monitoring solutions for natural resource and oceanographic applications. The addition of Sutron to the group is expected to provide many benefits, including the addition of core technologies in satellite communications, advanced air quality instrumentation, and highly sophisticated meteorological software solutions.

Read more: Sutron Corporation ( STRN )

Transgenomic Launches EGFR CLIA Test That Accurately Detects Key Mutations in Solid and Liquid Patient Samples Using Multiplexed ICE COLD-PCR™

EGFR Tests for Lung and Colon Cancer Are First of Series of CLIA Mutation Detection Tests that Leverage Multiplexed ICE COLD-PCR’s Outstanding Accuracy and Sensitivity and Its Ability to Work with Multiple Patient Sample Types

2015 ASCO Study Abstract Confirms Clinical Utility of Expanded Screening of KRAS and NRAS Genes in Colorectal Cancer Patients Using Transgenomic’s CRC RAScan™ Companion Diagnostic Test

Learn More about Transgenomic’s Expertise in Cancer Patient Testing and Its New Ultra-Sensitive MX-ICP CLIA Mutation Testing at ASCO Booth 12071

Read more: Transgenomic Inc ( TBIO )

Videos / Webinars

View all videos